Future Stars - SBA Biotech Pitch Session
Pitching session summary

The Future Stars – SBA Biotech Pitch Session showcases a curated group of high-quality Swiss biotech companies developing innovative solutions across therapeutics, diagnostics, and enabling technologies. Each company will present its vision, science, and value proposition in a concise pitch, followed by a live Q&A. The session offers investors, partners, and industry leaders early insight into the next wave of Swiss biotech innovation.

Date, time and room information

Monday, May 4, 16:30 - 18:15, room Shanghai 3+4

Moderation
Name Position Institution
Urech David Vice President Swiss Biotech Association
Ernst Bettina Vice President Swiss Biotech Association
Pitching companies
Company name Pitcher Title of presentation Link to company website
Allegria Therapeutics AG Patrick Sieber Mastering Mast Cells. https://allegriatx.com/
Aukera Therapeutics GmbH Stefan Imseng https://www.aukera-tx.com/
ClearideBio Therapeutics AG Xiaona Jing https://www.clearidebiotx.com/
Immitra Bio GmbH Amir Taheri https://immitrabio.com/
InkoCell Mathieu Girardin Transforming Immune Cells into Next-Gen Therapies https://www.inkocell.com/
InkVivo Technologies AG Elia Guzzi Data‑Driven Biomaterials for Smarter Drug Formulation https://inkvivo.tech/
INTERAX Andrew Roberts https://interaxbiotech.com/
MetaLead Michal Shoshan MetaLead’s journey from chelation therapy to radioligand therapy https://metalead.ch/
MyoPax Verena Schoewel MyoPax: Vanguard Cell and Gene Therapies for Muscle Repair https://myopax.com/
Nerai Bioscience Vincent Forster One editor, many cures: scalable genome editing for rare diseases https://nerai.bio/
Phialogics Natalia Novac Phialogics-native biologics platform restoring immune balance https://www.phialogics.net/
Seito Biologics AG Ufuk Karakus https://www.seitobio.ch/
Jury members
Name Position Institution
Luca Bollinger
Markus Goebel
Patrick Burgermeister
Swiss Biotech Association